These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 15993276

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Leukemic recombinations involving heterochromatin in myeloproliferative disorders with t(1;9).
    Sambani C, La Starza R, Pierini V, Vandenberghe P, Gonzales-Aguilera JJ, Rigana H, Koumbi D, Manola KN, Stavropoulou C, Georgakakos VN, Pagoni M, Wlodarska I, Mecucci C.
    Cancer Genet Cytogenet; 2005 Oct 01; 162(1):45-9. PubMed ID: 16157199
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
    Panani AD.
    Cancer Lett; 2007 Sep 18; 255(1):12-25. PubMed ID: 17383090
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinicopathological features of unbalanced translocation Der(1;7)(q10;p10) in myeloid neoplasms.
    So CC, Ma ES, Wan TS, Yip SF, Chan LC.
    Leuk Res; 2008 Jun 18; 32(6):1000-1. PubMed ID: 17980911
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders.
    Rege-Cambrin G, Speleman F, Kerim S, Scaravaglio P, Carozzi F, Dal Cin P, Michaux JL, Offner F, Saglio G, Van den Berghe H.
    Leukemia; 1991 Dec 18; 5(12):1059-63. PubMed ID: 1774954
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gains on 9p are common genomic aberrations in idiopathic myelofibrosis: a comparative genomic hybridization study.
    Al-Assar O, Ul-Hassan A, Brown R, Wilson GA, Hammond DW, Reilly JT.
    Br J Haematol; 2005 Apr 18; 129(1):66-71. PubMed ID: 15801957
    [Abstract] [Full Text] [Related]

  • 14. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
    Kreipe HH.
    Veroff Pathol; 1993 Apr 18; 141():1-158. PubMed ID: 8372486
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
    Larsen TS, Hasselbalch HC, Pallisgaard N, Kerndrup GB.
    Cancer Genet Cytogenet; 2007 Jan 15; 172(2):107-12. PubMed ID: 17213018
    [Abstract] [Full Text] [Related]

  • 18. Inverted duplication dup(1)(q32q21) as sole aberration in lymphoid and myeloid malignancies.
    Bacher U, Schnittger S, Grüneisen A, Haferlach T, Kern W, Haferlach C.
    Cancer Genet Cytogenet; 2009 Jan 15; 188(2):108-11. PubMed ID: 19100515
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.